EpiVax Therapeutics
Manon Cox is a member of the Scientific Advisory Board at Epivax. She is also the CEO of NextWaveBio.
This person is not in the org chart
This person is not in any offices
EpiVax Therapeutics
EpiVax Therapeutics ("EVT"), founded in 2017, employs a world-leading technology, developed over 22 years by EpiVax, to design vaccines that aim to activate the body’s T cells to cure or prevent disease in the host.